According to 180 Life Sciences's latest financial reports the company's current EPS (TTM) is -HK$186.02. In 2022 the company made an earnings per share (EPS) of -HK$150.22 a decrease over its 2021 EPS that were of -HK$111.54.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$187.59 | 24.88% |
2022 | -HK$150.22 | 34.68% |
2021 | -HK$111.54 | 8.79% |
2020 | -HK$102.53 |